Item 8.01 Other Events.
Press Release
On
announcing the initiation of its Phase 2/3 POPLAR-NF2 trial for the treatment of
NF2-mutated meningiomas. A copy of the press release is attached hereto as
Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release, dated
104 Cover Page Interactive Data File (formatted as Inline XBRL)
--------------------------------------------------------------------------------
© Edgar Online, source
